LSI Alumni remain on a solid trend in both healthcare and medical technology. As LSI Asia ‘26 in Singapore, alumni companies made significant regulatory approvals, clinical successes, executive moves, strategic partnerships, and industry growth in the last week.
These developments highlight not only the continued progress in healthcare innovation, but also the evolving medtech industry trends shaping the future of medical devices, diagnostics, robotics, neurotechnology, and women’s health.
Leadership Development & Strategy Building
New executive and board members filled the leadership ranks for several LSI Alumni groups.
APEX Biologic
APEX Biologic added a new Board of Directors member: Jeff Cambra. Cambra has a wealth of experience in the following areas:
- Medical devices
- Therapeutics
- Commercial strategy
- Portfolio management
- Product development
- Strategic transactions
His appointment will bolster the company’s growth and commercialization plans.
Dioscuri Technologies
Ray Baker, M.D. joined Dioscuri Technologies’ Board of Directors and served on the company in a fractional Chief Medical Officer position.
Dr. Baker brings over 30 years of experience in the following areas:
Interventional pain management
- Spine care
- Clinical strategy
- Regulatory planning
- Market-access initiatives
- Micro sure
Alex Joseph has been named Chief Executive Officer as the company moves from product development to clinical deployment. As the company moves from product development to clinical deployment, Alex Joseph has been appointed as Chief Executive Officer of Micro sure.
The company will concentrate on:
- Expanding clinical evidence
- Promoting the use of robotic super microsurgery.
- Advancing commercialization efforts
Business moves like these persist as key signals of major trends in the medtech sector, where experienced leadership is key to growing innovative healthcare businesses.
Advancements in Clinical Innovation
Several LSI Alumni companies reported significant clinical advances in both therapeutic and diagnostic areas.
Aqua Medical
Aqua Medical highlighted 12-month clinical outcomes of its proprietary radiofrequency (RF) vapor ablation technology for the treatment of type 2 diabetes outside the U.S.
Favourable safety observations
The outpatient procedure is developed to aid long-term metabolic therapy via proximal intestinal mucosal ablation.
Calla Lily Clinical Care
Calla Lily Clinical Care treated the first patient in a clinical trial of Call avid in women diagnosed with luteal phase insufficiency.
- The company is working on the therapy as a first-in-class innovation in:
- Threatened miscarriage prevention
Fertility support
The luteal phase is supported in IVF procedures. Luteal phase support during IVF.
Set Point Medical
Set Point Medical began enrolling patients in a pilot study of the Set Point SystemⓇ in adults with relapsing-remitting multiple sclerosis (MS) after receiving FDA IDE approval.
The company’s neuroimmune modulation platform also has been awarded
Inclusion on the FDA TAP Program
The developments reflect the continuing trend in the medtech industry for more personalized patient care, minimally invasive treatment methods and more-targeted therapies.
Regulatory and Quality Milestones
A significant measure of momentum in the medtech ecosystem is regulatory progress and movement.
Bright Uro
The wireless urodynamics platform, now with FDA 510(k) clearance for the GleanⓇ Abdominal Sensor, now provides a new level of insight into a patient’s urinary tract health.
Now the system is supporting:
- Multi-channel urodynamic studies
- Catheter-free ambulatory diagnostics
- Evaluation of the lower urinary tract function in the clinic.
E-Scopes
E-Scopes has been cleared by the FDA to enhance its Hepatoscopy platform with a new spleen examination workflow to aid in non-invasive assessment of cirrhosis.
The new platform features:
- Optimized acquisition parameters
- Spleen-specific measurement workflows
Greater reliability of stiffness assessments. Greater reliability to stiffness assessments.
Panda Surgical
Panda Surgical has been certified with ISO 13485:2016, underlining the company’s dedication to quality management standards in the medical devices industry.
The certification emphasizes:
- Product consistency
- Risk management
- Traceability
Regulatory compliance
Regulatory advancement will continue to be a key medtech industry trend, especially for companies looking to commercialize and expand their use in healthcare.
Robotic and AI continue growing in medtech. Robotic and AI are on the continuous expansion curve in medtech.
The use of robotics and AI-driven systems is becoming more common in a growing number of specialties.
Interventional Systems
Interventional Systems said that it has formed a strategic alliance with ProVoyance to investigate combined robotic navigation system capabilities.
The collaboration combines:
- Micromate™ robotic technology
- Software for pre-operative planning using Artificial Intelligence.
- Integrated navigation workflows
The partnership will focus on establishing end-to-end solutions for OEM partners, surgeons and healthcare systems.
MMI – Medical Micro instruments
MMI performed the initial procedure on the Samani Surgical System in their REMIND U.S. IDE Study.
The study is examining the feasibility of microsurgical methods in the neck area for new pathways through which lymphatic drainage may be restored for treating Alzheimer’s disease.
Precision IO Group
Precision IO Group announced the start of the EPIOS clinical study of Quantum Survival’s Epigone robotic system for the treatment of bone tumours and metastases.
The robotic platform is meant to assist physicians in the treatment of tumours in hard-to-reach anatomical sites. The recent advances show that automation, robotics, and intelligent systems are still shaping the key trends in surgery and in procedural care in the medtech industry.
The development of neurotechnology and advanced devices. Advances in neurotechnology and device development. New clinical and diagnostic advances continued to be made in the neurotechnology business, as well.
Sansome
Sansome released outcomes of its CLOT OUT first-in-human study using ClotildⓇ Smart Guidewire System.
The study demonstrated the system’s ability to:
- Differentiate surrounding anatomy from clot.
- Determine clot boundaries in thrombectomy procedures
- Provide procedural direction in stroke intervention.
Solaris Endovascular
The Solaris Endovascular drug-eluting covered stent (DEC) for haemodialysis patients was granted FDA Breakthrough Device Designation.
The device combines:
- A self-expanding nitinol scaffold
- The barrier technology is based on electrospinning PTFE.
- Targeted sirolimus-eluting coating
The innovation is designed to aid in better vascular patency during dialysis access procedure.
The continuing proliferation of industry partnerships and the growing access to healthcare services. Growth in industry partnerships and healthcare access.
Another key area for LSI Alumni companies was strategic partnerships.
Gramedia
Gramedia worked with LovellⓇ Government Services to facilitate access to healthcare in federal systems such as:
Veterans’ Health Administration
- Military Health System
- Indian Health Service
It is hoped that the alliance will increase access to the company’s Hypro Cure technology.
Ortho bullets
Andrew Morris was welcomed as a Strategic Advisor by Ortho bullets and additional expertise was provided in:
- Business development
- Commercial strategy
- medtech growth initiatives
- Tanya Ridding
TMR Executive Search is a specialist company established by LSI Alumni Tanya Ridding specialising in leadership recruitment in the medtech industry.
The firm will help:
- Founders and CEOs
- Board-level hiring
- Scaling organizations
- Expansion-stage healthcare companies
Looking Ahead
The LSI Alumni network’s newest innovations reflect ongoing momentum in the field of healthcare innovation, robotics, diagnostics, women’s health, neurotechnology, and AI-powered systems.
These advancements reflect regulatory approvals, clinical trials, leadership changes, and strategic partnerships that are impacting the healthcare sector and influencing the global medical technology landscape. LSI Alumni driving medtech innovation and healthcare breakthroughs come together at the LSI USA Summit. Connect with the founders, investors, and clinicians leading the next generation of medical technology. Learn more at lsiusasummit.com.